HILLEMAN JERYL L 4

What Happened Jeryl L. Hilleman, a director of Omada Health, Inc. (OMDA), was granted 1,299 restricted stock units (RSUs) on July 5, 2026. The Form 4 reports the grant at $0.00 per share (transaction code A), meaning these are compensation awards rather than an open‑market purchase; the Form 4 shows a $0 cash amount for the acquisition.

Key Details

• Transaction date and price: 2026-07-05; 1,299 RSUs @ $0.00 (award/grant).
• Filing: Form 4 filed with the SEC on 2026-07-07 (no late filing indicated).
• Shares owned after the transaction: Not disclosed on the provided Form 4.
• Footnote: The RSUs were granted under the Issuer’s Non‑Employee Director Compensation Program in lieu of retainer fees. Each RSU equals the right to one share of common stock, with settlement either on a date selected by the director under the Program or as otherwise provided by the Program.

Context This transaction is a routine director compensation award, not a market purchase or sale. RSU grants give the director the right to receive shares in the future (subject to the Program’s terms and any vesting/settlement rules) and do not by themselves indicate immediate buying or selling activity. The economic value realized will depend on Omada’s stock price at settlement.